POSA150 Cost-Effectiveness Analysis of First-Line (1L) Systemic Treatments in Advanced Renal Cell Carcinoma (aRCC) in France
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.291
https://www.valueinhealthjournal.com/article/S1098-3015(21)02086-6/fulltext
Title :
POSA150 Cost-Effectiveness Analysis of First-Line (1L) Systemic Treatments in Advanced Renal Cell Carcinoma (aRCC) in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02086-6&doi=10.1016/j.jval.2021.11.291
First page :
Section Title :
Open access? :
No
Section Order :
11067